RxDoctor Payments Data

Andra Talaska

Medical · Grand Rapids, MINPI 1336537877

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 563 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 45 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,580in general payments, 2019–2025

Across 563 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$1K
  • Novartis$1K
  • Abbott$824
  • Amgen$656
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$652
  • Bayer$647
  • plus $6K from 39 others

What the payments were for

  • Food & beverage$10,41298%
  • Education$1221%
  • Gifts$460%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,580 in reported general payments places this provider in the 90th percentile of 755 medical providers in Michigan.

See all medical providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban159$183,728
CamzyosMavacamten20$168,837
EntrestoSacubitril/Valsartan55$70,253
FarxigaDapagliflozin Propanediol36$32,132
JardianceEmpagliflozin30$31,698
XareltoRivaroxaban14$19,586
Repatha SureclickEvolocumab14$19,048
BrilintaTicagrelor22$9,573
Metoprolol Succinate319$8,518
Ezetimibe77$2,824
Rosuvastatin Calcium116$2,683
Ranolazine ErRanolazine37$2,609
Atorvastatin Calcium108$2,074
Losartan Potassium121$2,008
ClopidogrelClopidogrel Bisulfate87$1,787

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$507$183,728159 claims
E.r. Squibb & Sons, L.L.C.Camzyos$1,148$168,83720 claims
NovartisEntresto$1,059$70,25355 claims
AstraZenecaFarxiga, Brilinta$497$41,70458 claims
Boehringer IngelheimJardiance$493$31,69830 claims
Johnson & JohnsonXarelto$540$19,58614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 755 medical providers in Michigan.

Other medical in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →